PhaseV (Series A)

Funding Details
Awarder
RSS - theaiinsider.tech
Date Award
May 17, 2025
Vertical
AI/ML-driven clinical development
Funding URL
View Funding Page

Company Info
Traction
Used by over 30 global pharma companies across 20+ therapeutic areas, reducing trial costs by 50%, shortening duration by 40%, and boosting success rates by over 30%.
Organizations Involved
30 global pharma companies
Founders
Raviv Pryluk
Company Description
PhaseV provides AI-driven solutions for efficient clinical development and operations.
Market
Pharmaceuticals and Biotechnology
Location
USA
Coinvestors
Accel, Insight Partners, Viola Ventures, EXOR, LionBird

Links
Back to Home Back to AI/ML-driven clinical development Deals View Funding Announcement